Combination Chemotherapy in Treating Children With Refractory or Relapsed Hodgkin's Lymphoma
Status:
Completed
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as ifosfamide and vinorelbine, work in different
ways to stop cancer cells from dividing so they stop growing or die. Combining more than one
drug may kill more cancer cells.
PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy in treating
children who have refractory or relapsed Hodgkin's lymphoma.